AACR logo

More articles from Cancer Therapeutics Insights

NF-κB Inhibition by Bortezomib Permits IFN-γ–Activated RIP1 Kinase–Dependent Necrosis in Renal Cell Carcinoma
Roshan J. Thapa, Peirong Chen, Mitchell Cheung, Shoko Nogusa, Jianming Pei, Suraj Peri, Joseph R. Testa, Siddharth Balachandran

Molecular Cancer Therapeutics Aug 2013, 12 (8) 1568-1578; DOI: 10.1158/1535-7163.MCT-12-1010
Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer
Tian Ma, Fabrizio Galimberti, Cherie P. Erkmen, Vincent Memoli, Fadzai Chinyengetere, Lorenzo Sempere, Jan H. Beumer, Bean N. Anyang, William Nugent, David Johnstone, Gregory J. Tsongalis, Jonathan M. Kurie, Hua Li, James DiRenzo, Yongli Guo, Sarah J. Freemantle, Konstantin H. Dragnev, Ethan Dmitrovsky

Molecular Cancer Therapeutics Aug 2013, 12 (8) 1545-1555; DOI: 10.1158/1535-7163.MCT-12-0933
Alternative Cytotoxic Effects of the Postulated IGF-IR Inhibitor Picropodophyllin In Vitro
Xuping Wu, Linda Sooman, Malin Wickström, Mårten Fryknäs, Christine Dyrager, Johan Lennartsson, Joachim Gullbo

Molecular Cancer Therapeutics Aug 2013, 12 (8) 1526-1536; DOI: 10.1158/1535-7163.MCT-13-0091
Modulation of OATP1B-Type Transporter Function Alters Cellular Uptake and Disposition of Platinum Chemotherapeutics
Cynthia S. Lancaster, Jason A. Sprowl, Aisha L. Walker, Shuiying Hu, Alice A. Gibson, Alex Sparreboom

Molecular Cancer Therapeutics Aug 2013, 12 (8) 1537-1544; DOI: 10.1158/1535-7163.MCT-12-0926
Regorafenib Inhibits Growth, Angiogenesis, and Metastasis in a Highly Aggressive, Orthotopic Colon Cancer Model
Lotfi Abou-Elkacem, Susanne Arns, Gunnar Brix, Felix Gremse, Dieter Zopf, Fabian Kiessling, Wiltrud Lederle

Molecular Cancer Therapeutics Jul 2013, 12 (7) 1322-1331; DOI: 10.1158/1535-7163.MCT-12-1162
Antiproliferative Effects of Continued Mitogen-Activated Protein Kinase Pathway Inhibition following Acquired Resistance to BRAF and/or MEK Inhibition in Melanoma
Matteo S. Carlino, Kavitha Gowrishankar, Catherine A.B. Saunders, Gulietta M. Pupo, Stephanie Snoyman, Xu Dong Zhang, Robyn Saw, Therese M. Becker, Richard F. Kefford, Georgina V. Long, Helen Rizos

Molecular Cancer Therapeutics Jul 2013, 12 (7) 1332-1342; DOI: 10.1158/1535-7163.MCT-13-0011
Triptolide Induces the Expression of miR-142-3p: A Negative Regulator of Heat Shock Protein 70 and Pancreatic Cancer Cell Proliferation
Tiffany N. MacKenzie, Nameeta Mujumdar, Sulagna Banerjee, Veena Sangwan, Aaron Sarver, Selwyn Vickers, Subbaya Subramanian, Ashok K. Saluja

Molecular Cancer Therapeutics Jul 2013, 12 (7) 1266-1275; DOI: 10.1158/1535-7163.MCT-12-1231
Resveratrol Induces Differentiation Markers Expression in Anaplastic Thyroid Carcinoma via Activation of Notch1 Signaling and Suppresses Cell Growth
Xiao-Min Yu, Renata Jaskula-Sztul, Kamal Ahmed, April D. Harrison, Muthusamy Kunnimalaiyaan, Herbert Chen

Molecular Cancer Therapeutics Jul 2013, 12 (7) 1276-1287; DOI: 10.1158/1535-7163.MCT-12-0841
Metabolomics Identifies Pyrimidine Starvation as the Mechanism of 5-Aminoimidazole-4-Carboxamide-1-β-Riboside-Induced Apoptosis in Multiple Myeloma Cells
Carolyne Bardeleben, Sanjai Sharma, Joseph R. Reeve, Sara Bassilian, Patrick Frost, Bao Hoang, Yijiang Shi, Alan Lichtenstein

Molecular Cancer Therapeutics Jul 2013, 12 (7) 1310-1321; DOI: 10.1158/1535-7163.MCT-12-1042
REST Negatively and ISGF3 Positively Regulate the Human STAT1 Gene in Melanoma
James Amalraj, Samuel J. Cutler, Ibtisam Ghazawi, Glen M. Boyle, Stephen J. Ralph

Molecular Cancer Therapeutics Jul 2013, 12 (7) 1288-1298; DOI: 10.1158/1535-7163.MCT-12-0923

Main menu

User menu

Search

More articles from Cancer Therapeutics Insights

Pages

Articles

Info for

About MCT